John Buchanan was appointed independent non-executive Deputy Chairman in 2005 and became Chairman in April 2006. He is Chairman of the Nominations Committee. He is Chairman of the International Chamber of Commerce (UK); Senior Independent Director of BHP Billiton Plc and Deputy Chairman and Senior Independent Director of Vodafone Group Plc. He was formerly Group Chief Financial Officer of BP Plc. Former Non Executive Directorships include Boots and AstraZeneca Plc.

Olivier joined the Board on 1 April 2011 and was appointed Chief Executive Officer on 14 April. Prior to joining Smith & Nephew from Pierre Fabre, where he was Chief Executive, he was the Executive Vice President at Abbott Laboratories with responsibility for the Pharmaceuticals division. He held a series of international roles at Abbott, who he joined in 2003, and was based in a number of locations, most recently in Chicago. Prior to Abbott he held a number of roles with GlaxoSmithKline ultimately as Senior Vice president for European Commercial Operations – Pharmaceuticals. Olivier holds a doctorate from the University of Paris and an MBA from HEC.

Adrian Hennah joined the Group and was appointed a director in June 2006. He was previously Chief Financial Officer of Invensys plc and held various senior positions within GlaxoSmithKline. Adrian is a member of the Supervisory Board of Reed Elsevier NV and a non-executive director of Reed Elsevier PLC.

Pam Kirby was appointed a director in March 2002. She is Chairman of the Ethics and Compliance Committee and a member of the Remuneration Committee. She is non-executive Chairman of Scynexis Inc and a non-executive director of Informa plc and Victrex plc

Brian Larcombe was appointed a director in March 2002 and is a member of the Audit and Remuneration Committees. He is a non-executive director of gategroup Holdings AG and Incisive Media Holdings Limited Previously he was Chief Executive Officer of 3i Group plc.

Joseph Papa was appointed a director in August 2008. He is Chairman of the Remuneration Committee and a member of the Audit and Ethics and Compliance Committees. He is Chairman and Chief Executive of Perrigo Company. Previously he was Chairman and Chief Executive Officer of the Pharmaceutical and Technology Services segment of Cardinal Health Inc and President and Chief Operating Officer of Watson Pharmaceuticals Inc

Ajay Piramal was appointed a director in January 2012. He is the Chairman of Piramal Group and Chairman of the Board of Governors of the Indian Institute of Technology, a Member of the Board of Dean’s Advisors at the Harvard Business School and Chairman of Pratham India.

Rolf Stomberg was appointed a director in 1998 and is a member of the Remuneration Audit and Nominations Committees. He is Chairman of Lanxess AG and a non-executive director of Hoyer GmbH, Biesterfeld AG and Severstal OAO.

Susan Henderson, MA, FCIS has had 25 years experience as a company secretary in a wide range of businesses covering Board support, corporate governance, corporate transactions, corporate social responsibility, pensions, insurance and employee and executive share plans. She joined Smith & Nephew in May 2009 as Company Secretary. She has previously held various company secretarial positions at Prudential, RMC and Amersham, where she was Deputy Secretary for 5 years prior to its takeover by GE in 2004.